Alzheimer's disease

The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.

The grant was awarded through the Alzheimer's Drug Discovery Foundation's Diagnostic Accelerator, a partnership between the charity and philanthropic partners.

The findings suggest a potential avenue to treat or prevent Alzheimer's disease, the researchers said.

The collaborators hope to establish new models of human disease using patient-derived stem cells, with support from Bloomberg Philanthropies.

The bill would provide additional funding to each NIH institute and center, and would follow a 5.4 percent budget increase received in fiscal 2019.

The blood-based test is designed to detect changes in levels of microRNAs that are enriched in specific brain regions affected by Alzheimer's disease.

Investigators identified dozens of Alzheimer's-related epigenetic signatures based on cytosine methylation and other profiles in Alzheimer's-related cell lines and patient samples.